Artelo Biosciences Closes $3 Mln Public Offering Of Common Stock And Pre-Funded Warrants

Source: NASDAQ Markets | Published: September 5, 2025, 11:05 pm | Read Original

Neutral 0.0

(RTTNews) - Artelo Biosciences, Inc. (ARTL), a clinical-stage biopharmaceutical company, announced the closing of its underwritten public offering of 640,924 shares of common stock at $4.40 per share and pre-funded warrants to purchase 40,894 shares at $4.399 per warrant.

Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.

More Like This

Glideslope AI

Artelo Biosciences Closes $3 Mln Public Offering Of Common Stock And Pre-Funded Warrants

(RTTNews) - Artelo Biosciences, Inc. (ARTL), a clinical-stage biopharmaceutical company, announced the closing of its underwritten public offering of 640,924 shares of common stock at $4.40 per share and pre-funded warrants to purchase 40,894 shares at $4.399 per warrant.

NASDAQ Markets • Sep 5, 2025 • Found on Glideslope.ai

Post hash: 47222903772209350343 • glideslope.ai/post/47222903772209350343

Sentiment

Neutral • Score: 0.0

-100 (Bearish) +100 (Bullish)

Fraywire Market Portal, Breaking Metrics Newsletter, and Glideslope AI are designed for informational purposes only. The content provided across these platforms—including, but not limited to, stock and crypto watchlists, price tracking, trade tracking, sentiment analysis, and news articles—should not be construed as financial advice or research reports. Users are encouraged to conduct their own research and consult with qualified financial professionals before making any investment decisions. While we strive to ensure the accuracy, completeness, and reliability of the information provided, Fraywire, Breaking Metrics, and Glideslope AI make no guarantees or warranties regarding the content's validity. By using these platforms, you acknowledge and agree that you are solely responsible for your own investment decisions and actions. Fraywire, Breaking Metrics, and Glideslope AI shall not be held liable for any losses or damages resulting from the use of the information provided.

Get Connected

Fraywire & Glideslope AI are Breaking Metrics productions.
Contact the developer for advertising opportunities, questions, and more at roy@rmahd.com

○ Subscribe
○ Fraywire+
○ Glideslope AI
○ Blog
○ RMAHD
○ Merch!

" selected code.

Pulse AI Analysis

Related Insights

More Like This

How This SCOTUS Term Could Boost Republican Efforts Before Midterms

Turing AI Institute boss denies accusations of 'toxic internal culture'

Republican senator warns time is running out to pass US crypto bill: Report

Tokenization platform tZero eyes 2026 IPO amid surge in crypto listing

Virginia Democrats kick off effort to create more blue congressional seats

Americans split along political lines over Bad Bunny’s Super Bowl pick